David A. Siegel Abbott Laboratories Transaction History
Two Sigma Advisers, LP
- $43.8 Billion
- Q2 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Abbott Laboratories stock. As of the latest transaction made, Two Sigma Advisers, LP holds 4,657,200 shares of ABT stock, worth $533 Million. This represents 1.1% of its overall portfolio holdings.
Number of Shares
4,657,200
Previous 2,019,000
130.67%
Holding current value
$533 Million
Previous $229 Million
110.88%
% of portfolio
1.1%
Previous 0.54%
Shares
25 transactions
Others Institutions Holding ABT
# of Institutions
3,164Shares Held
1.33BCall Options Held
8.63MPut Options Held
7.19M-
Vanguard Group Inc Valley Forge, PA166MShares$19 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$15 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.52 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8.22 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.55 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $200B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...